BiotequeROCO:4107 -0.43%84 Market Cap is NT$8,108 Mil as of Jul. 08, 2026. GuruFocus rates ROCO:4107 with a GF Score™ of 84/100 and a GF Value™ of NT$129.15 (Fairly Valued). Among 867 Medical Devices & Instruments companies, Bioteque ranks better than 59.52% on this metric.
Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Bioteque's share price for the quarter that ended in Dec. 2025 was NT$120.5. Bioteque's Shares Outstanding (EOP) for the quarter that ended in Dec. 2025 was 69 Mil. Therefore, Bioteque's market cap for the quarter that ended in Dec. 2025 was NT$8,350 Mil.
Bioteque's quarterly market cap
increased
from Jun. 2025 (NT$8,177 Mil) to Sep. 2025 (NT$8,281 Mil) and
increased
from Sep. 2025 (NT$8,281 Mil) to Dec. 2025 (NT$8,350 Mil).
Bioteque's annual market cap
increased
from Dec. 2023 (NT$7,623 Mil) to Dec. 2024 (NT$8,558 Mil) but then
declined
from Dec. 2024 (NT$8,558 Mil) to Dec. 2025 (NT$8,350 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Bioteque's Enterprise Value for Today is NT$7,038 Mil.
Bioteque (ROCO:4107) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Bioteque Market Cap Related Terms
Bioteque Market Cap Historical Data
* Premium members only.
The historical data trend for Bioteque's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ROCO:4107 vs ISRG, BDX, MDLN: Market Cap Comparison
For the Medical Instruments & Supplies subindustry, Bioteque's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Bioteque Market Cap vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Bioteque's Market Cap distribution charts can be found below:
* The bar in red indicates where Bioteque's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Bioteque's Market Cap for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Bioteque (ROCO:4107) has a Market Cap of NT$8,108 Mil as of Jul. 08, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Bioteque and its competitors. According to the industry distribution chart, Bioteque ranks #351 out of 867 companies in the Medical Devices & Instruments industry, placing it in the top 40.5%.
Is Bioteque's Market Cap too high?
Bioteque's current Market Cap is NT$8,108 Mil. Based on the distribution chart, Bioteque ranks #351 out of 867 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Bioteque has a GF Score™ of 84/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Bioteque's Market Cap compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Bioteque ranks #351 out of 867 companies for Market Cap. This puts Bioteque in the upper half of its industry. The industry median Market Cap is 121.11. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Medical Devices & Instruments company?
The median Market Cap among Medical Devices & Instruments companies is 121.11, based on 867 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Bioteque and its competitors. For the Medical Devices & Instruments industry, the median Market Cap is 121.11 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Bioteque's current Market Cap is NT$8,108 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bioteque stock overvalued right now?
Based on GuruFocus' analysis, Bioteque (ROCO:4107) is currently considered Fairly Valued. The stock's GF Value™ is NT$129.15, compared to a current price of NT$117.00 — trading 9.4% below its estimated fair value. The current Market Cap is NT$8,108 Mil. Bioteque's overall GF Score™ is 84/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Bioteque (ROCO:4107), the current Market Cap is NT$8,108 Mil as of Jul. 08, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Bioteque (ROCO:4107) Overvalued in 2026?
Based on GuruFocus' analysis, Bioteque stock appears to be undervalued.
The current stock price of NT$117.00 is trading 9.4% below its estimated GF Value™ of NT$129.15.
GuruFocus considers Bioteque to be Fairly Valued.
Key valuation signals for ROCO:4107:
Market Cap: NT$8,108 Mil
GF Value™: NT$129.15 vs. price of NT$117.00 (9.4% below fair value)
No single metric tells the full story. See the ROCO:4107 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Bioteque Corp is engaged in manufacturing, trading, and selling medical equipment and instruments. The company operates in different segments such as Manufacturing medical disposables for hemodialysis use, and selling them to dealers and retailers; Manufacturing and selling catheters for healthcare and medical PVC IV bags to medical organizations; Manufacturing and selling medical key components and inner catheters to the medical organization; and Other segment. Geographically, the company generates a majority of its revenue from Asia and the rest from North America, South America, and other regions.
84GF Score
Get the complete analysis for ROCO:4107
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:4107 has been successfully added to your 
